ITPA

Inosine triphosphate pyrophosphatase · Q9BY32 · ITPA on Sugi Atlas →

0 patent compounds predicted against ITPA, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ITPA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Alendronate Versus Denosumab in Kidney Transplant Patients PHASE2/PHASE3COMPLETED
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Preventing Acute Kidney Injury (AKI) in Pediatric Patients PHASE3UNKNOWN
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia PHASE1/PHASE2COMPLETED
NEO100 and High-Grade Meningioma PHASE2RECRUITING
A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia PHASE1/PHASE2RECRUITING
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase PHASE2COMPLETED
University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial PHASE1/PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors PHASE1COMPLETED
Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers PHASE1COMPLETED
A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors nanWITHDRAWN
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart nanUNKNOWN
Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders nanUNKNOWN
Catheter Placement for Hepatic Hydrothorax nanCOMPLETED
Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) nanCOMPLETED
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia nanRECRUITING
The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients nanUNKNOWN
Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly nanUNKNOWN
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis nanCOMPLETED
Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura nanUNKNOWN
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP) nanCOMPLETED
Exome Sequencing for Atypical Femoral Fractures nanCOMPLETED
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients nanACTIVE_NOT_RECRUITING
Studying Phosphorus Metabolism nanCOMPLETED
Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia nanCOMPLETED
Immune Signature of Palmoplantar Pustulosis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ITPA binder may also engage these)

ProteinNameSimilarity
Q2KIC5 1.000 Q2KIC5 →
Q9D892 1.000 Q9D892 →
Q2NLA8 1.000 Q2NLA8 →
D3ZW55 1.000 D3ZW55 →
F1NLH9 0.998 F1NLH9 →
F6Y089 0.996 F6Y089 →
D5GCI8 0.996 D5GCI8 →
Q4DRX4 0.995 Q4DRX4 →
A4R1J6 0.995 A4R1J6 →
F6HS55 0.995 F6HS55 →
E3QBC5 0.994 E3QBC5 →
A5WVX0 0.994 A5WVX0 →
A7RWC9 0.994 A7RWC9 →
D0MY11 0.994 D0MY11 →
C5WZH0 0.993 C5WZH0 →
A9VE54 0.993 A9VE54 →
Q2TX99 0.993 Q2TX99 →
Q9VMW7 0.993 Q9VMW7 →
B8BH95 0.992 B8BH95 →
Q7Q4F5 0.992 Q7Q4F5 →
B6TNW8 0.992 B6TNW8 →
C7YTE3 0.992 C7YTE3 →
Q16YB3 0.992 Q16YB3 →
Q4DBX5 0.992 Q4DBX5 →
Q1K4R6 0.992 Q1K4R6 →
C8V9B7 0.992 C8V9B7 →
C0NE84 0.992 C0NE84 →
E3KAB5 0.992 E3KAB5 →
Q7XDP2 0.991 Q7XDP2 →
Q5KPF3 0.991 Q5KPF3 →